Orbit Discovery

Orbit Discovery is a drug discovery company providing peptide lead identification services using a proprietary bead-based peptide display engine combined with microfluidic functional screening.

The platform screens libraries of over one billion natural and non-natural peptides against challenging cell-surface targets, including GPCRs, and outputs functional therapeutic leads for peptide, peptidomimetic, and small molecule drug programmes.

Orbit serves pharmaceutical and biotechnology partners across oncology, radiopharmaceuticals, and oligonucleotide delivery applications.